About
SUBLIMED is a French healthcare startup founded in 2015 and based in Moirans, near Grenoble. The company focuses on developing connected medical devices aimed at alleviating chronic pain, particularly for patients with knee osteoarthritis. Its flagship product, actiTENS, is a flexible transcutaneous electrical neurostimulation (TENS) patch that can be placed anywhere on the body. This device is controlled via a smartphone app, making it convenient for users. The actiTENS has been clinically validated in a study involving 110 patients and is reimbursed by the French national health insurance system, enhancing accessibility for patients. With over 35,000 users in France, SUBLIMED has established a strong market presence and has received FDA approval for the US market. The company has a portfolio of six patents and collaborates with university medical centers to advance its technology. In 2023, SUBLIMED was acquired by Laboratoires Expanscience, which has further strengthened its position and supports its plans to innovate in areas like women’s health and endometriosis.
Technologies
Keywords
Company Information
-
Employees 14
-
Founded 2015
-
Annual Revenue $1000000
Location
137 Rue de Mayoussard, Moirans, Auvergne-Rhone-Alpes, France, 38430
